Hancock Whitney’s Corcept Therapeutics CORT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$557K Sell
7,594
-9,964
-57% -$731K 0.01% 540
2025
Q1
$2.01M Sell
17,558
-663
-4% -$75.7K 0.07% 207
2024
Q4
$918K Sell
18,221
-4,733
-21% -$238K 0.03% 326
2024
Q3
$1.06M Buy
22,954
+270
+1% +$12.5K 0.03% 305
2024
Q2
$737K Sell
22,684
-4,813
-18% -$156K 0.03% 348
2024
Q1
$693K Buy
27,497
+15,567
+130% +$392K 0.02% 367
2023
Q4
$387K Sell
11,930
-18
-0.2% -$585 0.01% 490
2023
Q3
$326K Sell
11,948
-432
-3% -$11.8K 0.01% 514
2023
Q2
$275K Sell
12,380
-5,092
-29% -$113K 0.01% 550
2023
Q1
$378K Sell
17,472
-2,564
-13% -$55.5K 0.02% 487
2022
Q4
$407K Sell
20,036
-75
-0.4% -$1.52K 0.02% 470
2022
Q3
$516K Sell
20,111
-467
-2% -$12K 0.02% 410
2022
Q2
$489K Sell
20,578
-789
-4% -$18.7K 0.02% 424
2022
Q1
$481K Sell
21,367
-4,366
-17% -$98.3K 0.02% 477
2021
Q4
$510K Sell
25,733
-203
-0.8% -$4.02K 0.02% 480
2021
Q3
$510K Sell
25,936
-93
-0.4% -$1.83K 0.02% 471
2021
Q2
$573K Sell
26,029
-7,755
-23% -$171K 0.02% 521
2021
Q1
$803K Sell
33,784
-484
-1% -$11.5K 0.03% 449
2020
Q4
$897K Sell
34,268
-197
-0.6% -$5.16K 0.03% 403
2020
Q3
$599K Sell
34,465
-171
-0.5% -$2.97K 0.02% 472
2020
Q2
$583K Sell
34,636
-4,241
-11% -$71.4K 0.02% 482
2020
Q1
$462K Buy
38,877
+11,117
+40% +$132K 0.02% 526
2019
Q4
$336K Sell
27,760
-14,760
-35% -$179K 0.01% 651
2019
Q3
$601K Sell
42,520
-5,902
-12% -$83.4K 0.02% 543
2019
Q2
$540K Buy
+48,422
New +$540K 0.02% 603